Remdesivir for COVID-19: Why Not Dose Higher?

被引：10

作者：

Yan, Victoria C. ^{[1
]}

Mueller, Florian L. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2021年 / 65卷 / 04期

关键词：

COVID-19; GS-441524; drug metabolism; prodrug; remdesivir;

D O I：

10.1128/AAC.02713-20

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页数：3

共 17 条

[1]

Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]

[2]

Boshier F.A.T., 2020, PREPRINT, DOI [10.1101/2020.11.18.20230599, DOI 10.1101/2020.11.18.20230599]

[3] Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis [J].

Dickinson, Peter J. ;

Bannasch, Michael ;

Thonnasy, Sara M. ;

Murthy, Vishal D. ;

Vernau, Karen M. ;

Liepnieks, Molly ;

Montgomery, Elizabeth ;

Knickelbein, Kelly E. ;

Murphy, Brian ;

Pedersen, Niels C. .

JOURNAL OF VETERINARY INTERNAL MEDICINE, 2020, 34 (04) :1587-1593

[4]

Food and Drug Administration, 2020, VEKLURY REMD

[5]

Gilead Sciences, 2020, GIL SCI STAT SOL TRI

[6] Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 [J].

Goldman, Jason D. ;

Lye, David C. B. ;

Hui, David S. ;

Marks, Kristen M. ;

Bruno, Raffaele ;

Montejano, Rocio ;

Spinner, Christoph D. ;

Galli, Massimo ;

Ahn, Mi-Young ;

Nahass, Ronald G. ;

Chen, Yao-Shen ;

SenGupta, Devi ;

Hyland, Robert H. ;

Osinusi, Anu O. ;

Cao, Huyen ;

Blair, Christiana ;

Wei, Xuelian ;

Gaggar, Anuj ;

Brainard, Diana M. ;

Towner, William J. ;

Munoz, Jose ;

Mullane, Kathleen M. ;

Marty, Francisco M. ;

Tashima, Karen T. ;

Diaz, George ;

Subramanian, Aruna .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) :1827-1837

[7] Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects [J].

Humeniuk, Rita ;

Mathias, Anita ;

Cao, Huyen ;

Osinusi, Anu ;

Shen, Gong ;

Chng, Estelle ;

Ling, John ;

Vu, Amanda ;

German, Polina .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05) :896-906

[8]

Li Y, 2020, BIORXIV, DOI [10.1101/2020.10.26.353300, DOI 10.1101/2020.10.26.353300]

[9] Remdesivir for COVID-19: challenges of underpowered studies [J].

Norrie, John David .

LANCET, 2020, 395 (10236) :1525-1527

[10] Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results [J].

Pan, Hongchao ;

Peto, Richard ;

Karim, Quarraisha Abdool ;

Alejandria, Marissa ;

Henao-Restrepo, Ana Maria ;

Garcia, Cesar Hernandez ;

Kieny, Marie Paule ;

Malekzadeh, Reza ;

Murthy, Srinivas ;

Preziosi, Marie-Pierre ;

Reddy, K. Srinath ;

Periago, Mirta Roses ;

Sathiyamoorthy, Vasee ;

Rottingen, John-Arne ;

Swaminathan, Soumya ;

Maggioni, Aldo ;

Babiker, Abdel ;

Cook, Deborah ;

Dondorp, Arjen ;

Kang, Gagandeep ;

Trelle, S. ;

McGinty, S. ;

Branca, M. ;

Appadoo, S. ;

Sterne, J. A. C. ;

Rogers, C. A. ;

Cappel-Porter, H. B. C. ;

Hutton, D. ;

Bellani, S. ;

Allum, E. ;

Kirwan, J. ;

Lydon, P. ;

Miranda-Montoya, M. C. ;

Salami, K. K. ;

Sathiyamoorthy, V. ;

Swaminathan, S. ;

Como, N. ;

Sinani, N. ;

Lopardo, G. ;

Periago, M. Roses ;

Nunes, E. P. ;

Reges, P. P. S. ;

Murthy, S. ;

Salvadori, M. ;

Alvarez-Moreno, C. A. ;

Rubio, M. L. Mesa ;

Hassany, M. ;

Zaid, H. ;

Tikkinen, K. A. O. ;

Perola, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06) :497-511

← 1 2 →